News + Filings Transactions
|
MCCORMICK FRANK
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 02/21/2023 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (right to buy) | 158.8k | $11.92 | $1.9M | | 02/21/2023 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Common Stock | 152.9k | $0.00 | $0 | | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Common Stock | 66.3k | $0.00 | $0 | See Footnote | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Series A-1 Convertible Preferred Stock | 152.9k | $0.00 | $0 | | 11/23/2020 |
| 11/23/2020 | Olema Pharmaceuticals, Inc. | OLMA | Conversion | Series A Convertible Preferred Stock | 66.3k | $0.00 | $0 | See Footnote | 11/23/2020 |
| 11/18/2020 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 21.5k | $19.00 | $408.9k | | 09/18/2020 |
| 11/13/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 10.1k | $43.57 | $438.7k | | 11/13/2020 |
| 11/13/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 58.3k | $42.91 | $2.5M | | 11/13/2020 |
| 11/13/2020 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 31.6k | $42.22 | $1.3M | | 11/13/2020 |
| 09/18/2020 | Olema Pharmaceuticals, Inc. | OLMA | Grant | Stock Option (Right to Buy) | 57k | $4.82 | $274.8k | | 09/18/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Common Stock | 39k | $0.00 | $0 | | 05/19/2020 |
| 05/19/2020 | BridgeBio Pharma, Inc. | BBIO | Grant | Stock Option (Right to Buy) | 10.5k | $1.05 | $11.1k | | 05/19/2020 |
| 12/30/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 900 | $36.86 | $33.2k | | 12/27/2019 |
| 12/30/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 16.2k | $35.74 | $580.8k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 100 | $42.93 | $4.3k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 617 | $42.26 | $26.1k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 883 | $41.31 | $36.5k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 16.9k | $40.13 | $676.4k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 13.7k | $39.27 | $538.2k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 3.5k | $38.09 | $133.3k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 21.7k | $36.85 | $797.9k | | 12/27/2019 |
| 12/27/2019 | BridgeBio Pharma, Inc. | BBIO | Sale | Common Stock | 25.5k | $36.37 | $928.6k | | 12/27/2019 |
| 07/01/2019 | BridgeBio Pharma, Inc. | BBIO | Exercise | Common Units | 47.2k | $0.00 | $0 | | 07/01/2019 |
| 07/01/2019 | BridgeBio Pharma, Inc. | BBIO | Exercise | Common Units | 132.3k | $0.00 | $0 | | 07/01/2019 |
| 07/01/2019 | BridgeBio Pharma, Inc. | BBIO | Exercise | Series B Units | 66.7k | $0.00 | $0 | | 07/01/2019 |
| 07/01/2019 | BridgeBio Pharma, Inc. | BBIO | Exercise | Management Incentive Units | 406.7k | $0.00 | $0 | | 07/01/2019 |
| 07/01/2019 | BridgeBio Pharma, Inc. | BBIO | Exercise | Management Incentive Units | 418k | $0.00 | $0 | | 07/01/2019 |
| 07/01/2019 | BridgeBio Pharma, Inc. | BBIO | Exercise | Management Incentive Units | 290.5k | $0.00 | $0 | | 07/01/2019 |
| 06/06/2018 | CHINOOK THERAPEUTICS, INC. | KDNY | Grant | Stock Option (Right to Buy) | 20k | $6.60 | $132k | | 06/06/2018 |
| 06/08/2017 | CHINOOK THERAPEUTICS, INC. | KDNY | Grant | Stock Option (Right to Buy) | 13k | $10.55 | $137.2k | | 06/08/2017 |
| 06/09/2016 | CHINOOK THERAPEUTICS, INC. | KDNY | Grant | Stock Option (Right to Buy) | 13k | $12.42 | $161.5k | | 06/09/2016 |
| 04/14/2015 | CHINOOK THERAPEUTICS, INC. | KDNY | Grant | Stock Option (right to buy) | 30k | $17.00 | $510k | | 04/14/2015 |
| 12/06/2013 | EXELIXIS, INC. | EXEL | Grant | Option (right to buy) | 66.1k | $5.82 | $384.5k | | 12/06/2013 |
|